By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Innovent Biologics has received China’s NMPA approval for the NDA for Tabosun, a CTLA-4 monoclonal antibody for colon cancer.

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

The devastating statistics about deaths from colon cancer have put the spotlight on a dreaded disease, which, today, could be ...

A diet rich in calcium can reduce the risk of developing bowel cancer, according to the results of a new study. Consuming foods rich in calcium could significantly reduce the risk of developing bowel ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer ...

Japanese golf legend Masashi Ozaki died at 78 after battling stage 4 sigmoid colon cancer. The disease develops in the lower ...